Has Kelly Hochstetler, PA received payments from drug or device companies?

Yes. Drug and device makers reported $7,831 in general payments to Kelly Hochstetler, PA across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kelly Hochstetler, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kelly Hochstetler, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kelly Hochstetler, PA

Medical · Dover, NHNPI 1659518280

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,072 of the $7,831 with a category attached, or 77.5%. Boston Scientific accounts for 62.8% of it on its own, with 15 other manufacturers making up the rest. Among medical clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,831in general payments, 2019–2025

Across 132 payments — averaging $59.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$5K
Nevro Corp.$671
Scilex Pharmaceuticals Inc.$403
Abbott$398
Nalu Medical, Inc.$318
Saluda Medical Americas, Inc.$211
plus $913 from 10 others

What the payments were for

Travel & lodging$1,75922%
Food & beverage$6,07278%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	70	$4,917
Nevro Corp.	21	$671
Scilex Pharmaceuticals Inc.	13	$403
Abbott	3	$398
Nalu Medical, Inc.	5	$318
Saluda Medical Americas, Inc.	3	$211
SPR Therapeutics, Inc	2	$177
Vertos Medical, Inc.	2	$156
Medtronic	1	$131
Pfizer	2	$95
Averitas Pharma Inc.	2	$87
Tonix Medicines, Inc.	1	$84
Biodelivery Sciences International, Inc.	3	$58
Pacira Pharmaceuticals Incorporated	1	$58
Vertex	2	$46
Collegium Pharmaceutical, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPECTRA WAVEWRITER$1,413
GENERAL PAIN MANAGEMENT$928
Intracept$631
Nalu Neurostimulation System$272
PROCLAIM$238
ETERNA$160
Evoke$159
SPRINT PNS System$149
mild Device Kit$139
Omnia$139
WaveWriter Alpha Prime 16$138
INTELLIS ADAPTIVESTIM$131
Senza$120
Superion Indirect Decompression System$106

How this compares

$7,831 in reported general payments places this provider in the 95th percentile of 124 medical providers in New Hampshire.

See all medical providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$36,962

Medicare patients

284

Services billed

576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	258	$5,070
Oxycodone Hcl	202	$4,923
Buprenorphine	24	$3,740
Fentanyl	36	$3,286
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	141	$3,143
Pregabalin	59	$2,530
Tramadol Hcl	164	$2,052
Morphine Sulfate ErMorphine Sulfate	58	$1,822
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	62	$1,711
Tizanidine Hcl	97	$1,366
Tramadol Hcl ErTramadol Hcl	26	$1,355
Celecoxib	14	$881
Cyclobenzaprine Hcl	58	$874
Methadone Hcl	39	$820
Morphine Sulfate	32	$611

Paid to pharmacies, not to this prescriber.

Other medical in Dover

Heather BigosDover$5K
Emily RushDover$347
Holly PelletierManchester$124K
Kathrine CecilNashua$9K
Alyssa DunnDerry$8K
Stacy FilionConcord$5K
Jacqueline FournierConcord$5K
Andrea BourkeLondonderry$5K
Dagan CloutierNashua$4K
Rachel WhitmanPortsmouth$3K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →